Javascript must be enabled to continue!
Empagliflozin targeting STAT3/Akt/Nrf2 axis promoting diabetic wound healing in rat model
View through CrossRef
BackgroundDiabetes mellitus (DM) and its complications pose a major global health challenge, with impaired wound healing leading to severe outcomes. Chronic inflammation, excessive proinflammatory cells, and high reactive oxygen species contribute to diabetic wound complications. Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has antioxidant and anti-inflammatory properties, but its impact on wound healing remains unclear.ObjectiveTo investigate the effects of empagliflozin on wound healing in diabetic rats and explore its underlying molecular mechanisms.MethodologyFifty male Wistar rats were divided into five groups: untreated diabetic rats (STZ group), STZ + plain hydrogel, STZ + empagliflozin hydrogel (1%), STZ + oral empagliflozin (20 mg/kg), and STZ + MEBO®. Wounds were created 2 weeks post-STZ injection and treated for 21 days. Assessments included wound contraction, histopathology, fasting blood glucose (FBG), oxidative stress parameters, and inflammatory biomarkers in skin homogenates. Mechanistic markers, including phosphorylated STAT3, Akt, nuclear factor erythroid 2-related factor 2 (Nrf2), sirtuin 1 (SIRT1), and β-catenin, were analyzed.ResultsEmpagliflozin-treated animals had significant wound healing improvements, confirmed by macroscopic and histological assessments, with oral administration being the most effective. Inflammatory markers, including tumor necrosis factor-alpha (TNF- α) and interleukin-6 (IL-6), were markedly reduced, alongside decreased oxidative stress. Both oral and topical empagliflozin significantly upregulated key proteins involved in healing, including phosphorylated STAT3, Akt, Nrf2, SIRT1, and β-catenin.ConclusionEmpagliflozin accelerates wound healing in diabetic rats through its anti-inflammatory and antioxidant properties. Oral empagliflozin exhibited superior efficacy, suggesting systemic effects that extend beyond glycemic control. These findings offer insights into its molecular mechanisms of empagliflozin as a promising therapeutic agent for diabetic wound management.
Title: Empagliflozin targeting STAT3/Akt/Nrf2 axis promoting diabetic wound healing in rat model
Description:
BackgroundDiabetes mellitus (DM) and its complications pose a major global health challenge, with impaired wound healing leading to severe outcomes.
Chronic inflammation, excessive proinflammatory cells, and high reactive oxygen species contribute to diabetic wound complications.
Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has antioxidant and anti-inflammatory properties, but its impact on wound healing remains unclear.
ObjectiveTo investigate the effects of empagliflozin on wound healing in diabetic rats and explore its underlying molecular mechanisms.
MethodologyFifty male Wistar rats were divided into five groups: untreated diabetic rats (STZ group), STZ + plain hydrogel, STZ + empagliflozin hydrogel (1%), STZ + oral empagliflozin (20 mg/kg), and STZ + MEBO®.
Wounds were created 2 weeks post-STZ injection and treated for 21 days.
Assessments included wound contraction, histopathology, fasting blood glucose (FBG), oxidative stress parameters, and inflammatory biomarkers in skin homogenates.
Mechanistic markers, including phosphorylated STAT3, Akt, nuclear factor erythroid 2-related factor 2 (Nrf2), sirtuin 1 (SIRT1), and β-catenin, were analyzed.
ResultsEmpagliflozin-treated animals had significant wound healing improvements, confirmed by macroscopic and histological assessments, with oral administration being the most effective.
Inflammatory markers, including tumor necrosis factor-alpha (TNF- α) and interleukin-6 (IL-6), were markedly reduced, alongside decreased oxidative stress.
Both oral and topical empagliflozin significantly upregulated key proteins involved in healing, including phosphorylated STAT3, Akt, Nrf2, SIRT1, and β-catenin.
ConclusionEmpagliflozin accelerates wound healing in diabetic rats through its anti-inflammatory and antioxidant properties.
Oral empagliflozin exhibited superior efficacy, suggesting systemic effects that extend beyond glycemic control.
These findings offer insights into its molecular mechanisms of empagliflozin as a promising therapeutic agent for diabetic wound management.
Related Results
Abstract 1404: Novel STAT3 inhibitors targeting the STAT3 dimerization
Abstract 1404: Novel STAT3 inhibitors targeting the STAT3 dimerization
Abstract
Background The STAT3 pathway may drive prostate cancer (PCa) progression to metastatic castration-resistant prostate cancer (mCRPC). STAT3 may serve as a go...
A Stress-Responsive Transcriptional Factor NRF2 Activates Hematopoietic Stem Cells
A Stress-Responsive Transcriptional Factor NRF2 Activates Hematopoietic Stem Cells
Abstract
KEAP1-NRF2 system is a major regulator of cellular redox balance and xenobiotic metabolism. NRF2 is an inducible transcription factor, and KEAP1 is its nega...
Abstract 1705: 3D growth modulates the competition between STAT3 and STAT5 in breast cancer
Abstract 1705: 3D growth modulates the competition between STAT3 and STAT5 in breast cancer
Abstract
Approximately 13% of women are diagnosed with invasive breast cancer. Signal Transducer and Activator of Transcription 3 (STAT3) is a transcription factor t...
Abstract 4699: Single domain antibody (sdAb) localizes in cancer cells to inhibit signal transducer and activator of transcription 3 (STAT3) resulting in therapeutic inhibition of multiple cancers
Abstract 4699: Single domain antibody (sdAb) localizes in cancer cells to inhibit signal transducer and activator of transcription 3 (STAT3) resulting in therapeutic inhibition of multiple cancers
Abstract
STAT3 is involved in the pathogenesis of many malignancies, so we developed an anti-STAT3 VHH (variable region of the heavy chain), SBT-100, that internaliz...
P–117 Bioinformatic analysis of NRF2 in the study of association of NRF2 variant and male infertility related to smoking status
P–117 Bioinformatic analysis of NRF2 in the study of association of NRF2 variant and male infertility related to smoking status
Abstract
Study question
Could Nrf2 polymorphism (–617C>A; rs6721961) and oxidative stress (OS)-induced changes of signatu...
P-117 Pre-selected for an award: Bioinformatic analysis of NRF2 in the study of association of NRF2 variant and male infertility related to smoking status
P-117 Pre-selected for an award: Bioinformatic analysis of NRF2 in the study of association of NRF2 variant and male infertility related to smoking status
Abstract
Study question
Could Nrf2 polymorphism (-617C>A; rs6721961) and oxidative stress (OS)-induced changes of signatu...
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Heart failure with reduced ejection fraction (HFrEF) remains a major clinical challenge worldwide and is a pressing public health issue in Pakistan. Patients here often present at ...
EFEKTIFITAS PERAWATAN LUKA METODE MOISTWOUND HEALING DAN METODE KONVENSIONAL TERHADAP PENYEMBUHAN LUKA PADA POST SIRKUMSISI METODE ELEKTRIK CAUTER DI KLINIK KHITAN SMART INDONESIA LAMANDAU
EFEKTIFITAS PERAWATAN LUKA METODE MOISTWOUND HEALING DAN METODE KONVENSIONAL TERHADAP PENYEMBUHAN LUKA PADA POST SIRKUMSISI METODE ELEKTRIK CAUTER DI KLINIK KHITAN SMART INDONESIA LAMANDAU
Abstrak
Sterilitas yang kurang baik pada saat sirkumsisi dan higiene pasca sirkumsisi yang tidak terjaga menyebabkan infeksi luka operasi, sehingga membutuhkan perawatan luka post ...

